Trafficking of APC from liver allografts of Flt3L-treated donors: Augmentation of potent allostimulatory cells in recipient lymphoid tissue is associated with a switch from tolerance to rejection

Transplant Immunology

Volumn 7, Issue 1, 1999, Pages 51-57

  Steptoe, Raymond J ^a   Li, Wei ^a   Fu, Fumin ^a   O'Connell, Peta J ^a   Thomson, Angus W ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD40 ANTIGEN; CD86 ANTIGEN; DNA; GLYCOPROTEIN P 15095; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ALLOGRAFT; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN PRESENTING CELL; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; FLOW CYTOMETRY; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOHISTOCHEMISTRY; IMMUNOLOGICAL TOLERANCE; IMMUNOSTIMULATION; LIVER TRANSPLANTATION; LYMPHOCYTE PROLIFERATION; LYMPHOID TISSUE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPLEEN; T LYMPHOCYTE; THYMUS;

EID: 0032892877     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0966-3274(99)80019-7     Document Type: Article

References (46)

1. Qian S, Demetris AJ, Murase N, Rao AS, Fung JJ, Starzl TE. Murine liver allograft transplantation: tolerance and donor cell chimerism. Hepatology. 19:1994;916-924.
2. Zimmerman FA, Butcher GW, Davies HffS, et al. Techniques for orthotopic liver transplantation in the rat and some studies of the immunologic responses to fully allogeneic liver grafts. Transplant Proc. 11:1979;571-577.
3. Calne RY, Sells RA, Pena JR, et al. Induction of immunological tolerance by porcine liver allografts. Nature. 233:1969;472-474.
4. Kamada N, Davies H, Roser B. Reversal of transplantation immunity by liver grafting. Nature. 292:1981;840-842.
5. Wood K, Farges O. Tolerance. Neuberger J, Adams D, . Immunology of liver transplantation. 1993;139-151 Little Brown, Boston, MA.
6. Kamada N. Animal models of liver transplantation and their clinical relevance. Neuberger J, Adams D, . Immunology of liver transplantation. 1993;161-186 Little Brown, Boston, MA.
7. Qian S, Thai NL, Lu L, Fung JJ, Thomson AW. Liver transplant tolerance: mechanistic insights from animal models, with particular reference to the mouse. Transplant Rev. 11:1997;151-164.
8. Starzl TE, Demetris AJ, Murase N, Ildstad S, Ricordi C, Trucco M. Cell migration, chimerism, and graft acceptance. Lancet. 339:1992;1579-1582.
9. Thomson AW, Lu L, Murase N, Demetris AJ, Rao AS, Starzl TE. Microchimerism, dendritic cell progenitors and transplantation tolerance. Stem Cells. 13:1995;622-639.
10. Woo J, Lu L, Rao AS, et al. Isolation, phenotype, and allostimulatory activity of mouse liver dendritic cells. Transplantation. 58:1994;484-491.
11. Lu L, Woo J, Rao AS, et al. Propagation of dendritic cell progenitors from normal mouse liver using granulocyte/macrophage colony-stimulating factor and their maturational development in the presence of type-1 collagen. J Exp Med. 179:1994;1823-1834.
12. -) induce alloantigen-specific hyporesponsiveness in murine T lymphocytes. Transplantation. 60:1995;1539-1545.
13. Lu L, Qian S, Hershberger P, Rudert WA, Lynch DA, Thomson AW. Fas ligand (CD95L) and B7 expression on dendritic cells provide counter-regulatory signals for T cell survival and proliferation. J Immunol. 158:1997;5676-5684.
14. -) prolong cardiac allograft survival in non-immunosuppressed recipients. Transplantation. 62:1996;659-665.
15. Rastellini C, Lu L, Ricordi C, Starzl TE, Rao AS, Thomson AW. Granulocyte-macrophage colony-stimulating factor-stimulated hepatic dendritic cell progenitors prolong pancreatic islet allograft survival. Transplantation. 60:1995;1366-1370.
16. + stem cells and thymocyte precursors in the livers of adult mice. J Exp Med. 184:1996;687-693.
17. Taniguchi H, Toyoshima T, Fukao K, Nakauchi H. Presence of hematopoietic stem cells in the adult liver. Nature Med. 2:1996;198-203.
18. Murase N, Starzl TE, Ye Q, et al. Multilineage hematopoietic reconstitution of supralethally irradiated rats by syngeneic whole organ transplantation: with particular reference to the liver. Transplantation. 61:1996;1-4.
19. Bishop GA, Sun J, De Cruz DJ, et al. Tolerance to rat liver allografts. III. Donor cell migration and tolerance-associated cytokine production in peripheral lymphoid tissues. J Immunol. 156:1995;4925-4931.
20. Steptoe RJ, Fu F, Li W, et al. Augmentation of dendritic cells in murine organ donors by Flt3 ligand alters the balance between transplant tolerance and immunity. J Immunol. 159:1997;5483-5491.
21. Qian S, Lu L, Fu F, et al. Donor pretreatment with Flt-3 ligand augments antidonor cytotoxic T lymphocyte, natural killer, and lymphokine-activated killer cell activities within liver allografts and alters the pattern of intragraft apoptotic activity. Transplantation. 65:1998;1590-1598.
22. Maraskovsky E, Brasel K, Teepe M, et al. In vivo administration of flt3 ligand results in generation of large numbers of dendritic cells in the lymphoid tissue of mice. J Exp Med. 184:1996;1953-1962.
23. Qian S, Fung JJ, Demetris AJ, Ildstad ST, Starzl TE. Orthotopic liver transplantation in mice. Transplantation. 52:1991;562-564.
24. Antonysamy MA, Steptoe RJ, Khanna A, Rudert WA, Subbotin VM, Thomson AW. Flt-3 ligand increases microchimerism but can prevent the therapeutic effect of donor bone marrow in transiently immunosuppressed cardiac allograft recipients. J Immunol. 160:1998;4106-4113.
25. Lu L, Rudert WA, Qian S, et al. Growth of donor-derived dendritic cells from the bone marrow of murine liver allograft recipients in response to granulocyte/macrophage colony-stimulating factor. J Exp Med. 182:1995;379-387.
26. Matsuno K, Ezaki T, Kudo S, Uehara Y. A life stage of particle-laden rat dendritic cells in vivo: their terminal division, active phagocytosis, and translocation from the liver to the draining lymph. J Exp Med. 183:1996;1865-1878.
27. Lyman SD, James L, Johnson L, et al. Cloning of the human homologue of the murine flt3 ligand: A growth factor for early hematopoietic progenitor cells. Blood. 83:1994;2795-2801.
28. Brasel K, McKenna HJ, Morrisey PJ, et al. Hematological effects of flt3 ligand in vivo in mice. Blood. 88:1996;2004-2012.
29. Fu F, Li W, Fung JJ, Thomson AW, Qian S. Treatment with CTLA4-Ig inhibits rejection of liver allografts from Flt3-Ligand-treated donors. Transplant Proc. 31:1999;453.
30. Starzl TE, Demetris AJ, Murase N, Trucco M, Thomson AW, Rao AS. The lost chord: microhimerism and allograft survival. Immunology Today. 17:1996;577-584.
31. Larsen CP, Morris PJ, Austyn JM. Migration of dendritic leukocytes from cardiac allografts into host spleens: a novel pathway for initiation of rejection. J Exp Med. 171:1990;307-314.
32. Austyn JM, Larsen CP. Migration patterns of dendritic leukocytes. Implications for transplantation. Transplantation. 49:1990;1-7.
33. Lechler RI, Batchelor JR. Restoration of immunogenicity to passenger cell-depleted kidney allografts by the addition of donor strain dendritic cells. J Exp Med. 155:1982;31-41.
34. Steinman RM. The dendritic cell system and its role in immunogenicity. Ann Rev Immunol. 9:1991;271-296.
35. Demetris AJ, Murase N, Fujisaki S, Fung JJ, Rao AS, Starzl TE. Hematolyphoid cell trafficking, microchimerism, and GVHD reactions after liver, bone marrow, and heart transplantation. Transplant Proc. 25:1993;3337-3344.
36. Thomson AW, Lu L, Subbotin VM, et al. In vitro propagation and homing of liver-derived dendritic cell progenitors to lymphoid tissues of allogeneic recipients. Transplantation. 59:1995;544-551.
37. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature. 392:1998;245-252.
38. Steptoe RJ, Thomson AW. Dendritic cells and tolerance induction. Clin Exp Immunol. 105:1996;397-402.
39. Lu L, Khoury SJ, Sayegh MH, Thomson AW. Dendritic cell tolerogenicity and prospects for dendritic cell-based therapy of allograft rejection and autoimmunity. Lotze MT, Thomson Aw, . Dendritic cells, Biology and clinical applications. 1999;486-571 Academic Press, San Diego, CA.
40. Thomas JM, Carver FM, Kasten-Jolly J, et al. Further studies of veto activity in rhesus monkey bone marrow in relation to allograft tolerance and chimerism. Transplantation. 57:1994;101-115.
41. D'Orazio TJ, Niederkorn JY. A novel role for TGF-β and IL-10 in the induction of immune privilege. J Immunol. 160:1998;2089-2098.
42. Süss G, Shortman K. A subclass of dendritic cells kills T cells via Fas/Fas ligand-induced apoptosis. J Exp Med. 183:1996;1789-1796.
43. Qian S, Lu L, Fu F, et al. Apoptosis within spontaneously accepted mouse liver allografts. Evidence for deletion of cytotoxic T cells and implications for tolerance induction. J Immunol. 158:1997;4654-4661.
44. Drakes ML, Lu L, Subbotin VM, Thomson AW. In vivo adminsitration of flt3 ligand markedly stimulates generation of dendritic cell progenitors from mouse liver. J Immunol. 159:1997;4268-4278.
45. Hayamizu K, Huie P, Sibley RK, Strober S. Monocyte-derived dendritic cell precursors facilitate tolerance to heart allografts after total lymphoid irradation. Transplantation. 66:1998;1285-1291.
46. Niimi M, Pearson TC, Larsen CP, et al. The role of the CD40 pathway in alloantigen-induced hyporesponsiveness in vivo. J Immunol. 161:1998;5331-5337.